The PIO II Study: In-office Post-op Placement of a Steroid-eluting Sinus Implant

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Chronic Sinusitis, Ethmoidal
Interventions
COMBINATION_PRODUCT

Steroid-eluting sinus implant

PROPEL (Intersect ENT, Inc., Menlo Park, CA), containing 370μg of mometasone furoate gradually released over 30 days

OTHER

Post-op standard of care

Post-op standard of care including debridement, irrigation, and/or topical steroids

Trial Locations (1)

75034

Collin County Ear Nose & Throat, Frisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Intersect ENT

INDUSTRY

lead

Collin County Ear Nose & Throat

OTHER